SeqWright Revenue and Competitors
Estimated Revenue & Valuation
- SeqWright's estimated annual revenue is currently $1.4M per year.
- SeqWright's estimated revenue per employee is $155,000
Employee Data
- SeqWright has 9 Employees.
- SeqWright grew their employee count by -18% last year.
SeqWright's People
Name | Title | Email/Phone |
---|
SeqWright Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 11 | -8% | N/A | N/A |
#2 | $14.9M | 96 | -6% | N/A | N/A |
#3 | $15.2M | 98 | 3% | $1.8M | N/A |
#4 | $1.6M | 10 | 0% | N/A | N/A |
#5 | $3.4M | 22 | 0% | N/A | N/A |
#6 | $2.8M | 18 | 50% | N/A | N/A |
#7 | $7.4M | 48 | -2% | N/A | N/A |
#8 | $0.8M | 5 | 0% | N/A | N/A |
#9 | $1.6M | 10 | 0% | N/A | N/A |
#10 | $16.3M | 105 | 62% | N/A | N/A |
What Is SeqWright?
Founded in 1994 by John W. Belmont, M.D., Ph.D. and Richard Gibbs, Ph.D., Director of the Human Genome Sequencing Center, SeqWright Inc. is a Contract Research Organization (CRO) specializing in Genomic Services. From its inception, Fei Lu, M.D. has run the company, fostering its growth from a small start-up, focused primarily on sequencing, to a powerful full-service Nucleic Acid Technology CRO with services ranging from Molecular Biology, to Microarray, to Next Generation Genomics. SeqWright is CLIA certified and GLP compliant, which enables us to offer FDA and GLP-level services; a strength we have leveraged to provide Clinical Trial support services to the Pharmaceutical Industry and Genomics Services to the USDA. With over 14 years of Genomics experience, we have earned a reputation for quality service, technical expertise, and a willingness to customize services to meet our client’s individual needs.
keywords:N/AN/A
Total Funding
9
Number of Employees
$1.4M
Revenue (est)
-18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.2M | 9 | 0% | $10.4M |
#2 | $1.1M | 9 | -83% | N/A |
#3 | $0.7M | 9 | N/A | N/A |
#4 | $0.7M | 9 | N/A | N/A |
#5 | $1.1M | 9 | N/A | N/A |